發炎性腸道疾病:全球臨床實驗回顧

本報告提供全球發炎性腸道疾病治療藥物的臨床實驗的相關調查，各地區臨床實驗數資料，實驗階段，實驗情形，採用題目及各類型贊助企業的臨床實驗資料，中斷(暫時停止，廢止，停止)的實驗清單等資料，為您概述為以下內容。

目錄

目錄

• 表格一覽
• 圖表一覽
• 簡介
• 發炎性腸道疾病
• 報告指南
• 臨床實驗 , 各地區
• 臨床實驗 , 各國
• 對臨床實驗有所貢獻的前五國 - 亞太地區
• 對臨床實驗有所貢獻的前五國 - 歐洲
• 對臨床實驗有所貢獻的前幾名國家 - 北美
• 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
• 對臨床實驗有所貢獻的前幾名國家 - 中南美
• 臨床實驗 金磚四國 各國
• 臨床實驗 G7 各國
• 臨床實驗 - G7 各國 , 各臨床實驗狀態
• 臨床實驗 E7 各國
• 臨床實驗 - E7 各國 , 各臨床實驗狀態
• 臨床實驗 各階段
• 進行中的臨床實驗 各階段
• 臨床實驗 , 各臨床實驗狀態
• 未完成的臨床實驗; 發炎性腸道疾病
• 每段時期的實驗人數
• 有力的贊助商
• 前幾名參與企業 - 發炎性腸道疾病 治療藥物的臨床實驗
• 潛力治療藥物比較
• 臨床實驗簡介
• 臨床實驗概要; 前幾名企業
• Johnson & Johnson
• 臨床實驗概要; Johnson & Johnson
• Pharmacosmos A/S
• 臨床實驗概要; Pharmacosmos A/S
• Given Imaging Ltd.
• 臨床實驗概要; Given Imaging Ltd.
• Pfizer Inc.
• 臨床實驗概要; Pfizer Inc.
• Vifor Pharma Ltd.
• 臨床實驗概要; Vifor Pharma Ltd.
• Merck & Co., Inc.
• 臨床實驗概要; Merck & Co., Inc.
• GlaxoSmithKline plc
• 臨床實驗概要; GlaxoSmithKline plc
• AstraZeneca PLC
• 臨床實驗概要; AstraZeneca PLC
• Salix Pharmaceuticals, Ltd.
• 臨床實驗概要; Salix Pharmaceuticals, Ltd.
• Abbott Laboratories
• 臨床實驗概要; Abbott Laboratories
• Zealand Pharma A/S
• 臨床實驗概要; Zealand Pharma A/S
• Ocera Therapeutics, Inc.
• 臨床實驗概要; Ocera Therapeutics, Inc.
• Eisai公司
• 臨床實驗概要; Eisai公司
• SBL Vaccines AB
• 臨床實驗概要; SBL Vaccines AB
• Novogen Limited
• 臨床實驗概要; Novogen Limited
• 4SC AG
• 臨床實驗概要; 4SC AG
• Shire Plc
• 臨床實驗概要; Shire Plc
• Ranbaxy Laboratories Limited
• 臨床實驗概要; Ranbaxy Laboratories Limited
• Danisco A/S
• 臨床實驗概要; Danisco A/S
• Chiesi Farmaceutici SpA
• 臨床實驗概要; Chiesi Farmaceutici SpA
• 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
• Tel-Aviv Sourasky Medical Center
• 臨床實驗概要; Tel-Aviv Sourasky Medical Center
• The National Institute of Allergy and Infectious Diseases
• 臨床實驗概要; the National Institute of Allergy and Infectious Diseases
• University of Pittsburgh
• 臨床實驗概要; University of Pittsburgh
• University of Alberta
• 臨床實驗概要; University of Alberta
• Children's Hospital Boston
• 臨床實驗概要; Children's Hospital Boston
• Indiana University
• 臨床實驗概要; Indiana University
• Academic Medical Centre
• 臨床實驗概要; Academic Medical Centre
• Beth Israel Deaconess Medical Center
• 臨床實驗概要; Beth Israel Deaconess Medical Center
• Johns Hopkins University
• 臨床實驗概要; Johns Hopkins University
• VU University Medical Center
• 臨床實驗概要; VU University Medical Center
• 大阪大學
• 臨床實驗概要; 大阪大學
• Department of Health
• 臨床實驗概要; Department of Health
• University of Pennsylvania
• 臨床實驗概要; University of Pennsylvania
• University Hospital, Grenoble
• 臨床實驗概要; University Hospital, Grenoble
• University of California, Irvine
• 臨床實驗概要; University of California, Irvine
• Vanderbilt University
• 臨床實驗概要; Vanderbilt University
• Cedars-Sinai Medical Center
• 臨床實驗概要; Cedars-Sinai Medical Center
• Asan Medical Center
• 臨床實驗概要; Asan Medical Center
• The University of Adelaide
• 臨床實驗概要; The University of Adelaide
• 東京醫科齒科大學
• 臨床實驗概要; 東京醫科齒科大學

附錄

• 簡稱
• 定義
• 調查方法
• 二級研究
• 關於GlobalData
• 諮詢方式
• 免責聲明
• 資訊來源

表格一覽

表格一覽

• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 各地區
• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 , 各國排名
• 發炎性腸道疾病 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
• 發炎性腸道疾病 治療藥物的臨床實驗, 亞太地區, 前五國
• 發炎性腸道疾病 治療藥物的臨床實驗, 歐洲, 前五國
• 發炎性腸道疾病 治療藥物的臨床實驗, 北美, 前幾名國家
• 發炎性腸道疾病 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
• 發炎性腸道疾病 治療藥物的臨床實驗, 中南美, 前幾名國家
• 發炎性腸道疾病 治療藥物的臨床實驗, 金磚四國 各國
• 發炎性腸道疾病 治療藥物的臨床實驗, G7 各國
• 發炎性腸道疾病 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
• 發炎性腸道疾病 治療藥物的臨床實驗, E7 各國
• 發炎性腸道疾病 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 各階段
• 發炎性腸道疾病 全球治療藥物市場, 進行中的臨床實驗 各階段
• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
• 發炎性腸道疾病 全球治療藥物市場, 中止的臨床實驗
• 發炎性腸道疾病 全球治療藥物市場, 終止的臨床實驗
• 發炎性腸道疾病 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
• 發炎性腸道疾病 全球治療藥物臨床實驗, 主要的贊助商
• 發炎性腸道疾病 全球治療藥物臨床實驗, 前幾名企業 各階段
• 發炎性腸道疾病 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Johnson & Johnson
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Pharmacosmos A/S
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Given Imaging Ltd.
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Pfizer Inc.
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Vifor Pharma Ltd.
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Merck & Co., Inc.
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- GlaxoSmithKline plc
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- AstraZeneca PLC
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Salix Pharmaceuticals, Ltd.
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Abbott Laboratories
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Zealand Pharma A/S
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Ocera Therapeutics, Inc.
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Eisai公司
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- SBL Vaccines AB
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Novogen Limited
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- 4SC AG
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Shire Plc
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Ranbaxy Laboratories Limited
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Danisco A/S
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Chiesi Farmaceutici SpA
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Tel-Aviv Sourasky Medical Center
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- The National Institute of Allergy and Infectious Diseases
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- University of Pittsburgh
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- University of Alberta
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Children's Hospital Boston
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Indiana University
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Academic Medical Centre
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Beth Israel Deaconess Medical Center
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Johns Hopkins University
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- VU University Medical Center
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- 大阪大學
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Department of Health
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- University of Pennsylvania
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- University Hospital, Grenoble
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- University of California, Irvine
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Vanderbilt University
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Cedars-Sinai Medical Center
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- Asan Medical Center
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- The University of Adelaide
• 發炎性腸道疾病 全球治療藥物臨床實驗市場, 臨床實驗- 東京醫科齒科大學

圖表一覽

圖表一覽

• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 各地區 (%)
• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 , 各國排名
• 發炎性腸道疾病 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
• 發炎性腸道疾病 治療藥物的臨床實驗, 亞太地區, 前五國 (%)
• 發炎性腸道疾病 治療藥物的臨床實驗, 歐洲, 前五國 (%)
• 發炎性腸道疾病 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
• 發炎性腸道疾病 治療藥物的臨床實驗, 中東及非洲, 前幾名國家 (%)
• 發炎性腸道疾病 治療藥物的臨床實驗, 中南美, 前幾名國家 (%)
• 發炎性腸道疾病 治療藥物的臨床實驗, 金磚四國 各國 (%)
• 發炎性腸道疾病 治療藥物的臨床實驗, G7 各國 (%)
• 發炎性腸道疾病 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
• 發炎性腸道疾病 治療藥物的臨床實驗, E7 各國 (%)
• 發炎性腸道疾病 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 各階段 (%)
• 發炎性腸道疾病 全球治療藥物市場, 進行中的臨床實驗 各階段
• 發炎性腸道疾病 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
• 發炎性腸道疾病 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
• 發炎性腸道疾病 全球治療藥物臨床實驗, 主要的贊助商
• 發炎性腸道疾病 全球治療藥物臨床實驗, 前幾名企業 各階段
• 發炎性腸道疾病 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
• GlobalData 調查方法

Abstract

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, "Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012" provides data on the Inflammatory Bowel Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammatory Bowel Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inflammatory Bowel Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Inflammatory Bowel Disease Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Inflammatory Bowel Disease, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

TOC

Table of Contents

Table of Contents 2

• List of Tables 5
• List of Figures 7
• Introduction 8
• Inflammatory Bowel Disease 8
• Report Guidance 8
• Clinical Trials by Region 9
• Clinical Trials by Country 10
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
• Top Five Countries Contributing to Clinical Trials in Europe 13
• Top Countries Contributing to Clinical Trials in North America 14
• Top Countries Contributing to Clinical Trials in Middle East and Africa 15
• Top Countries Contributing to Clinical Trials in Central and South America 16
• Clinical Trials by BRIC Nations 17
• Clinical Trials by G7 Nations 18
• Clinical Trials in G7 Nations by Trial Status 19
• Clinical Trials by E7 Nations 20
• Clinical Trials in E7 Nations by Trial Status 21
• Clinical Trials by Phase 22
• In Progress Trials by Phase 23
• Clinical Trials by Trial Status 24
• Unaccomplished Trials of Inflammatory Bowel Disease 25
• Subjects Recruited Over a Period of Time 32
• Prominent Sponsors 33
• Top Companies Participating in Inflammatory Bowel Disease Therapeutics Clinical Trials 35
• Prominent Drug Comparison 37
• Clinical Trial Profiles 38
• Clinical Trial Overview of Top Companies 38
• Abbott Laboratories 38
• Clinical Trial Overview of Abbott Laboratories 38
• Merck & Co., Inc. 40
• Clinical Trial Overview of Merck & Co., Inc. 40
• Pfizer Inc. 42
• Clinical Trial Overview of Pfizer Inc. 42
• UCB S.A. 44
• Clinical Trial Overview of UCB S.A. 44
• GlaxoSmithKline plc 45
• Clinical Trial Overview of GlaxoSmithKline plc 45
• UCB, Inc. 46
• Clinical Trial Overview of UCB, Inc. 46
• Johnson & Johnson 47
• Clinical Trial Overview of Johnson & Johnson 47
• Alba Therapeutics Corporation 48
• Clinical Trial Overview of Alba Therapeutics Corporation 48
• AstraZeneca PLC 49
• Clinical Trial Overview of AstraZeneca PLC 49
• Sanofi 50
• Clinical Trial Overview of Sanofi 50
• Teva Pharmaceutical Industries Limited 51
• Clinical Trial Overview of Teva Pharmaceutical Industries Limited 51
• Alvine Pharmaceuticals, Inc. 52
• Clinical Trial Overview of Alvine Pharmaceuticals, Inc. 52
• Cytokine PharmaSciences, Inc. 53
• Clinical Trial Overview of Cytokine PharmaSciences, Inc. 53
• Osiris Therapeutics, Inc. 54
• Clinical Trial Overview of Osiris Therapeutics, Inc. 54
• Bristol-Myers Squibb Company 55
• Clinical Trial Overview of Bristol-Myers Squibb Company 55
• Given Imaging Ltd. 56
• Clinical Trial Overview of Given Imaging Ltd. 56
• Zeria Pharmaceutical Co Ltd 57
• Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 57
• Elan Pharmaceuticals, Inc 58
• Clinical Trial Overview of Elan Pharmaceuticals, Inc 58
• Dr. Falk Pharma GmbH 59
• Clinical Trial Overview of Dr. Falk Pharma GmbH 59
• Janssen Biotech, Inc. 60
• Clinical Trial Overview of Janssen Biotech, Inc. 60
• Clinical Trial Overview of Top Universities / Institutes / Hospitals 61
• Tel-Aviv Sourasky Medical Center 61
• Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 61
• Academic Medical Centre 62
• Clinical Trial Overview of Academic Medical Centre 62
• University of Pittsburgh 63
• Clinical Trial Overview of University of Pittsburgh 63
• Indiana University 64
• Clinical Trial Overview of Indiana University 64
• Mayo Clinic 65
• Clinical Trial Overview of Mayo Clinic 65
• Hyogo College Of Medicine 66
• Clinical Trial Overview of Hyogo College Of Medicine 66
• Vanderbilt University 67
• Clinical Trial Overview of Vanderbilt University 67
• Beth Israel Deaconess Medical Center 68
• Clinical Trial Overview of Beth Israel Deaconess Medical Center 68
• VU University Medical Center 69
• Clinical Trial Overview of VU University Medical Center 69
• University of Alberta 70
• Clinical Trial Overview of University of Alberta 70
• University of Zurich 71
• Clinical Trial Overview of University of Zurich 71
• Children's Hospital Boston 72
• Clinical Trial Overview of Children's Hospital Boston 72
• Keio University 73
• Clinical Trial Overview of Keio University 73
• Tokyo Medical and Dental University 74
• Clinical Trial Overview of Tokyo Medical and Dental University 74
• Assistance Publique - Hopitaux de Paris 75
• Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 75
• Hadassah Medical Organization 76
• Clinical Trial Overview of Hadassah Medical Organization 76
• Northwestern University 77
• Clinical Trial Overview of Northwestern University 77
• The University of British Columbia 78
• Clinical Trial Overview of The University of British Columbia 78
• Asan Medical Center 79
• Clinical Trial Overview of Asan Medical Center 79
• University of Erlangen-Nurnberg 80
• Clinical Trial Overview of University of Erlangen-Nurnberg 80
• Five Key Clinical Profiles 81

Appendix 213

• Abbreviations 213
• Definitions 213
• Research Methodology 214
• Secondary Research 214
• About GlobalData 215
• Contact Us 215
• Disclaimer 215
• Source 216

List of Tables

List of Tables

• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
• Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
• Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries, 2012* 17
• Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries, 2012* 18
• Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
• Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries, 2012* 20
• Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
• Inflammatory Bowel Disease Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
• Inflammatory Bowel Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
• Inflammatory Bowel Disease Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 32
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 34
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 36
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 37
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 38
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 40
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 42
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2012* 44
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 45
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB, Inc., 2012* 46
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 47
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alba Therapeutics Corporation, 2012* 48
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 49
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 50
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 51
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alvine Pharmaceuticals, Inc., 2012* 52
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokine PharmaSciences, Inc., 2012* 53
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osiris Therapeutics, Inc., 2012* 54
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 55
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Given Imaging Ltd., 2012* 56
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2012* 57
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Elan Pharmaceuticals, Inc, 2012* 58
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2012* 59
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Biotech, Inc., 2012* 60
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012* 61
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 62
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 63
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2012* 64
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 65
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2012* 66
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 67
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 68
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012* 69
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2012* 70
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2012* 71
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2012* 72
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2012* 73
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical and Dental University, 2012* 74
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 75
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012* 76
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 77
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2012* 78
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 79
• Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Erlangen-Nurnberg, 2012* 80

List of Figures

List of Figures

• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
• Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
• Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
• Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
• Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
• Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
• Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
• Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 32
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35
• Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 37
• GlobalData Methodology 214